26 June 2024
Session 5 – 9:30 AM to 11:00 AM
| 9:30 AM | Invited Speaker The discovery of selective USP7 inhibitors Ben Davis, Vernalis |
| 10:00 AM | Accelerating hit-to-lead discovery: approaches to improve off-rate screening by surface plasmon resonance Jason Pun, Monash University |
| 10:30 AM | Discovery of novel calcium-sensing receptor allosteric modulators using fragment-based drug design approaches Gilbert Song, Monash University |
Networking Break
Session 6 – 11:30 AM to 12:30 PM
| 11:30 AM | Invited Speaker Animal venom peptides as proxies for function in screening of deconstructed ion channels Mehdi Mobli, The University of Queensland |
| 12:00 PM | Structural determination of human P2X7 ion channel receptor using cryoEM Xuefei Jing, The University of Sydney |
Networking Lunch
Session 7 – 1:30 PM to 3:30 PM
| 1:30 PM | Invited Speaker Crystal clear insights: automation in fragment screening crystallography Dr Kate Smith, Paul Scherrer Institut |
| 2:00 PM | Invited Speaker Establishing high throughput crystallisation labs with fragment screening capabilities Dr Roxanne Smith, The University of Melbourne |
| 2:30 PM | Development of a fragment screening platform at the Australian Synchrotron Gautham Balaji, Monash University/ANSTO |
| 2:50 PM | Fragment-based drug discovery at the Australian Synchrotron Yogesh Khandokar, ANSTO – Australian Synchrotron |
| 3:10 PM | Q&A session on crystallography |
Networking Break
Session 8 – 4:00 PM to 5:30 PM
| 4:00 PM | Finding patentable chemical space in FBDD James Burnley, Phillips Ormonde Fitzpatrick |
| 4:30 PM | Funding Opportunities – Panel Discussion TIA, Med-Chem Australia, CUREator, BioCurate, Phillip Ormond Fitzpatrick |
Conference Dinner at Customs House